331 related articles for article (PubMed ID: 28929450)
1. Intrarenal Angiotensin-Converting Enzyme: the Old and the New.
Culver S; Li C; Siragy HM
Curr Hypertens Rep; 2017 Sep; 19(10):80. PubMed ID: 28929450
[TBL] [Abstract][Full Text] [Related]
2. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
Zhuo JL; Li XC
Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
[TBL] [Abstract][Full Text] [Related]
3. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease.
Wysocki J; González-Pacheco FR; Batlle D
Curr Hypertens Rep; 2008 Feb; 10(1):70-7. PubMed ID: 18367030
[TBL] [Abstract][Full Text] [Related]
5. The intrarenal renin-angiotensin system: does it exist? Implications from a recent study in renal angiotensin-converting enzyme knockout mice.
Lu X; Roksnoer LC; Danser AH
Nephrol Dial Transplant; 2013 Dec; 28(12):2977-82. PubMed ID: 23901049
[TBL] [Abstract][Full Text] [Related]
6. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
Zhao S; Ghosh A; Lo CS; Chenier I; Scholey JW; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Endocrinology; 2018 Feb; 159(2):836-852. PubMed ID: 29211853
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 and renal disease.
Williams VR; Scholey JW
Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):35-41. PubMed ID: 29045335
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of angiotensin-converting enzyme-2 in the kidney.
Burns KD
Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686
[TBL] [Abstract][Full Text] [Related]
11. The intrarenal generation of angiotensin II is required for experimental hypertension.
Giani JF; Shah KH; Khan Z; Bernstein EA; Shen XZ; McDonough AA; Gonzalez-Villalobos RA; Bernstein KE
Curr Opin Pharmacol; 2015 Apr; 21():73-81. PubMed ID: 25616034
[TBL] [Abstract][Full Text] [Related]
12. The intrarenal renin-angiotensin system in hypertension.
Carey RM
Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
[TBL] [Abstract][Full Text] [Related]
13. ACE2, a new regulator of the renin-angiotensin system.
Burrell LM; Johnston CI; Tikellis C; Cooper ME
Trends Endocrinol Metab; 2004; 15(4):166-9. PubMed ID: 15109615
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat.
Rivière G; Michaud A; Breton C; VanCamp G; Laborie C; Enache M; Lesage J; Deloof S; Corvol P; Vieau D
Hypertension; 2005 Nov; 46(5):1169-74. PubMed ID: 16203874
[TBL] [Abstract][Full Text] [Related]
15. Sequential activation of the intrarenal renin-angiotensin system in the progression of hypertensive nephropathy in Goldblatt rats.
Kim YG; Lee SH; Kim SY; Lee A; Moon JY; Jeong KH; Lee TW; Lim SJ; Sohn IS; Ihm CG
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F195-206. PubMed ID: 26823279
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the intrarenal renin-angiotensin system in experimental alport syndrome.
Bae EH; Konvalinka A; Fang F; Zhou X; Williams V; Maksimowski N; Song X; Zhang SL; John R; Oudit GY; Pei Y; Scholey JW
Am J Pathol; 2015 May; 185(5):1423-35. PubMed ID: 25777062
[TBL] [Abstract][Full Text] [Related]
17. Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio.
Wakahara S; Konoshita T; Mizuno S; Motomura M; Aoyama C; Makino Y; Kato N; Koni I; Miyamori I
Endocrinology; 2007 May; 148(5):2453-7. PubMed ID: 17303661
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease.
Tikellis C; Bernardi S; Burns WC
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):62-8. PubMed ID: 21099686
[TBL] [Abstract][Full Text] [Related]
19. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
Kobori H; Nangaku M; Navar LG; Nishiyama A
Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
[TBL] [Abstract][Full Text] [Related]
20. Altered renal expression of angiotensin II receptors, renin receptor, and ACE-2 precede the development of renal fibrosis in aging rats.
Schulman IH; Zhou MS; Treuer AV; Chadipiralla K; Hare JM; Raij L
Am J Nephrol; 2010; 32(3):249-261. PubMed ID: 20689271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
